Outset Medical markets the Tablo portable dialysis system. The company has growth opportunities in acute care and in-home dialysis. Outset Medical's biggest challenge is execution in lowering its cost ...
After kicking off the year by shipping out a record number of its Tablo hemodialysis systems for at-home users, Outset Medical has brought those sales to a screeching halt. The California-based ...
The FDA cleared Outset's Tablo dialysis device for home use. Home dialysis presents an $8.9 billion annual market opportunity for Outset. Reimbursement changes should help boost use of Tablo in home ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”) today announced that its Tablo® Hemodialysis System has received the first-ever approval from the Centers for Medicare & ...
SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (“Outset″), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of ...
The Tablo System promises to make dialysis easier and more convenient for patients. But there are significant barriers to the technology. By Dawn MacKeen This article is part of Upstart, a series ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Fifty-seven year old dialysis patient Tracey Amadi of central New Jersey is the first person in the world to use Outset Medical’s mobile Tablo Hemodialysis System at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback